WallStreetZenWallStreetZen

NASDAQ: INO
Inovio Pharmaceuticals Inc Stock Ownership - Who owns Inovio Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Inovio Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Michael John SumnerChief Medical Officer2025-05-15680$1.95
$1.33kSell
Laurent HumeauChief Scientific Officer2025-05-151,708$1.95
$3.33kSell
Peter KiesCFO2025-05-152,566$1.95
$5.00kSell
Jacqueline Elizabeth SheaChief Executive Officer2025-05-157,717$1.95
$15.05kSell
Jacqueline Elizabeth SheaChief Executive Officer2025-05-102,392$1.80
$4.31kSell
Laurent HumeauChief Scientific Officer2025-02-261,584$1.98
$3.14kSell
Jacqueline Elizabeth SheaChief Executive Officer2025-02-262,493$1.98
$4.94kSell
Peter KiesCFO2025-02-262,960$1.98
$5.86kSell
Laurent HumeauChief Scientific Officer2025-02-262,059$1.98
$4.08kSell
Peter KiesCFO2025-02-262,362$1.98
$4.68kSell

1 of 2

INO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when INO insiders and whales buy or sell their stock.

INO Shareholders

What type of owners hold Inovio Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Austin W. Greenhouse David M. Marxe56.31%20,650,987$27.47MInsider
Tee Khiang Ng13.36%4,899,931$6.52MInsider
Deep Track Capital LP8.51%3,119,162$4.15MInstitution
Jong Joseph Kim6.40%2,346,000$3.12MInsider
Blackrock Inc6.32%2,318,480$3.08MInstitution
Vanguard Group Inc5.53%2,028,960$2.70MInstitution
Bank Of America Corp3.56%1,304,987$1.74MInstitution
Geode Capital Management LLC2.31%846,803$1.13MInstitution
Beng Lee Gan2.24%823,045$1.09MInsider
Kevin Rassas1.98%726,088$965.70kInsider

1 of 3

INO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
INO30.46%69.54%Net SellingNet Selling
CRVO3.23%96.77%Net BuyingNet Buying
VTVT0.94%99.06%Net Buying
DTIL12.12%87.88%Net SellingNet Buying
HOWL47.80%52.20%Net BuyingNet Buying
View Top Biotech Stocks

Inovio Pharmaceuticals Stock Ownership FAQ

Who owns Inovio Pharmaceuticals?

Inovio Pharmaceuticals (NASDAQ: INO) is owned by 37.08% institutional shareholders, 84.67% Inovio Pharmaceuticals insiders, and 0.00% retail investors. Austin W. Greenhouse David M. Marxe is the largest individual Inovio Pharmaceuticals shareholder, owning 20.65M shares representing 56.31% of the company. Austin W. Greenhouse David M. Marxe's Inovio Pharmaceuticals shares are currently valued at $27.47M.

If you're new to stock investing, here's how to buy Inovio Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.